Lorazepam and Muscle Spasms: Clinical Guidance
Lorazepam does not cause muscle spasms; rather, benzodiazepines including both lorazepam and clonazepam (Klonopin) are actually used to treat muscle spasm, though neither is a first-line choice and both carry significant risks, particularly in older adults. 1
Understanding Benzodiazepines and Muscle Effects
Mechanism of Action
- Benzodiazepines activate GABA-A receptors in the brain and have known effects on muscle spasm relief, not muscle spasm induction 1
- Both lorazepam and clonazepam possess muscle relaxant properties through their benzodiazepine receptor activity 1, 2
- These agents may be justified for relief of muscle spasm, especially when anxiety, muscle spasm, and pain coexist 1
Clinical Evidence for Muscle Relaxation
- If muscle spasm is suspected as the root cause of pain, benzodiazepines (including both lorazepam and clonazepam) are considered appropriate alternatives to traditional muscle relaxants 1
- Clonazepam specifically has demonstrated effectiveness for pain due to muscle spasm in case reports, with both muscle relaxant and anxiolytic effects 3
- Diazepam (another benzodiazepine) has been shown to directly reduce muscle contraction amplitude and isometric twitch tension in patients with spasticity 4
Comparing Lorazepam vs. Clonazepam
Pharmacological Differences
- Lorazepam has a shorter elimination half-life (8-15 hours) and no active metabolites 1
- Clonazepam has a longer duration of action, which may provide more sustained muscle relaxation 1
- Both agents carry similar mechanisms for muscle relaxation through benzodiazepine/GABA receptor systems 2
Safety Profile: Neither is "Safer"
Switching from lorazepam to clonazepam does not improve safety—both carry identical high-risk profiles, particularly for older adults. 1
- Both agents cause respiratory depression, hypotension, sedation, cognitive impairment, and increased fall risk 1
- Both are associated with delirium risk, especially in older patients 1
- Both cause tolerance, dependence, and withdrawal syndromes with prolonged use 1
- The high risk profile in older adults usually obviates any potential benefit for pain or muscle spasm relief 1
Specific Risks Common to Both Agents
- Central nervous system depression: drowsiness, dizziness, fatigue, lightheadedness 1, 5
- Increased fall risk and motor skill impairment 1
- Cognitive impairment and slowed comprehension 1
- Paradoxical agitation and anxiety in some patients 1
- Risk of propylene glycol toxicity with lorazepam formulations (metabolic acidosis, acute kidney injury) 1
Clinical Recommendations
When Benzodiazepines May Be Considered for Muscle Spasm
- Only when muscle spasm is clearly identified as the pain source 1
- When anxiety, muscle spasm, and pain coexist 1
- For short-term use only (days, not weeks) 5
- At the lowest effective dose 1
Preferred Alternatives to Both Agents
If muscle spasm treatment is needed, consider baclofen as a first-line alternative rather than switching between benzodiazepines. 1
- Baclofen is specifically recommended for severe spasticity and muscle spasm due to CNS injury or neuromuscular disorders 1
- Baclofen has documented efficacy for muscle spasm without the same abuse potential as benzodiazepines 1
- Start baclofen at low doses and gradually increase to minimize dizziness, somnolence, and GI symptoms 1
Critical Pitfalls to Avoid
- Do not prescribe traditional "muscle relaxants" (cyclobenzaprine, methocarbamol, carisoprodol) believing they relieve muscle spasm—their effects are nonspecific and not related to actual muscle relaxation 1
- Avoid long-term benzodiazepine use (>2 weeks) due to accumulating adverse effects, particularly drowsiness and dizziness (NNTH 3) 5
- Be aware that even short-term benzodiazepine use (24 hours to 2 weeks) is associated with significant adverse events 5
- Never assume one benzodiazepine is "safer" than another for muscle spasm—the class effects are consistent 1